167 related articles for article (PubMed ID: 24080334)
1. Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.
Allahham A; Stewart PJ; Das SC
Int J Pharm; 2013 Nov; 457(1):101-9. PubMed ID: 24080334
[TBL] [Abstract][Full Text] [Related]
2. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
Tay T; Allahham A; Morton DA; Stewart PJ
Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
[TBL] [Abstract][Full Text] [Related]
3. Understanding agglomeration of indomethacin during the dissolution of micronised indomethacin mixtures through dissolution and de-agglomeration modeling approaches.
Stewart PJ; Zhao FY
Eur J Pharm Biopharm; 2005 Feb; 59(2):315-23. PubMed ID: 15661504
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.
Allahham A; Stewart PJ
Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551
[TBL] [Abstract][Full Text] [Related]
5. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
Tay T; Allahham A; Morton DA; Stewart PJ
J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
[TBL] [Abstract][Full Text] [Related]
6. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
Le VN; Robins E; Flament MP
Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
[TBL] [Abstract][Full Text] [Related]
7. De-agglomeration of micronized benzodiazepines in dissolution media measured by laser diffraction particle sizing.
Zhao FY; Stewart PJ
J Pharm Pharmacol; 2003 Jun; 55(6):749-55. PubMed ID: 12841934
[TBL] [Abstract][Full Text] [Related]
8. Drug agglomeration and dissolution--what is the influence of powder mixing?
Kale K; Hapgood K; Stewart P
Eur J Pharm Biopharm; 2009 May; 72(1):156-64. PubMed ID: 19347972
[TBL] [Abstract][Full Text] [Related]
9. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
10. Agglomerate formation and growth mechanisms during melt agglomeration in a rotary processor.
Vilhelmsen T; Schaefer T
Int J Pharm; 2005 Nov; 304(1-2):152-64. PubMed ID: 16198077
[TBL] [Abstract][Full Text] [Related]
11. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
[TBL] [Abstract][Full Text] [Related]
12. Powder strength distributions for understanding de-agglomeration of lactose powders.
Das SC; Behara SR; Bulitta JB; Morton DA; Larson I; Stewart PJ
Pharm Res; 2012 Oct; 29(10):2926-35. PubMed ID: 22695732
[TBL] [Abstract][Full Text] [Related]
13. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
Dave RH; Patel AD; Donahue E; Patel HH
Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
[TBL] [Abstract][Full Text] [Related]
14. Different effects of silica added internal or external on in vitro dissolution of indomethacin hot-melt extrudates.
Xia Y; Yuan M; Deng Y; Ke X; Ci T
Int J Pharm; 2017 Dec; 534(1-2):272-278. PubMed ID: 29074389
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence investigation of a specific structure formed by aggregation of transglycosylated stevias: solubilizing effect of poorly water-soluble drugs.
Uchiyama H; Tozuka Y; Asamoto F; Takeuchi H
Eur J Pharm Sci; 2011 May; 43(1-2):71-7. PubMed ID: 21463678
[TBL] [Abstract][Full Text] [Related]
16. Impact of altered hydrophobicity and reduced agglomeration on dissolution of micronized poorly water-soluble drug powders after dry coating.
Kim S; Bilgili E; Davé RN
Int J Pharm; 2021 Sep; 606():120853. PubMed ID: 34252519
[TBL] [Abstract][Full Text] [Related]
17. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
[TBL] [Abstract][Full Text] [Related]
18. New binary solid dispersion of indomethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement.
Sivert A; Bérard V; Andrès C
J Pharm Sci; 2010 Mar; 99(3):1399-413. PubMed ID: 19827098
[TBL] [Abstract][Full Text] [Related]
19. Dissolution rate enhancement of gliclazide by ordered mixing.
Saharan VA; Choudhury PK
Acta Pharm; 2011 Sep; 61(3):323-34. PubMed ID: 21945911
[TBL] [Abstract][Full Text] [Related]
20. Elaboration and structural analysis of aquasomes loaded with indomethacin.
Rojas-Oviedo I; Salazar-López RA; Reyes-Gasga J; Quirino-Barreda CT
Eur J Pharm Sci; 2007 Nov; 32(3):223-30. PubMed ID: 17905573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
